2023 EpiCast Report: Atrial Fibrillation Market Epidemiology

1
EpiCast Report Atrial Fibrillation -
Epidemiology Forecast to 2023 www.bigmarketres
earch.com
2
Report Description
Summary Atrial fibrillation (AF) is a disorder
of the hearts electrical system. The condition
is characterized by an irregular heart rhythm
that is either too fast or too slow. During AF,
the two upper chambers of the heart (atria) beat
out of coordination with the two lower chambers
(ventricles) due to disorganized electrical
signals, resulting in poor blood supply to the
lungs and the rest of the body. The symptoms of
AF typically include heart palpitations,
irregular and fast heartbeat, chest discomfort,
shortness of breath, dizziness, and weakness.
However, individuals with AF may be asymptomatic
and not even know that they have the condition
until it is identified through an
electrocardiogram (EKG or ECG) test. Browse
complete report _at_ http//www.bigmarketresearch.co
m/epicast-report-atrial-fibrillation-epidemiology-
forecast-to-2023-market
3
Report Description
AF is one of the most common cardiovascular
diseases among the elderly, worldwide. Although
AF affects people of all ages, the condition is
rare in individuals younger than 40 years of age.
The risk for AF increases rapidly with age and is
more common in men than women. Globally, the
prevalence of AF varies widely, depending on the
country and the study, ranging from 0.1-1.6 in
Asia (0.1 in India, 1.6 in Japan), 0.95-3.9 in
North America (0.95 in the US, 3.9 in Canada),
1.28-2.1 in Europe (1.28 in the UK, 2.1 in
Germany), and 4.0 in Australia. GlobalData
epidemiologists forecast that the diagnosed
prevalent cases of AF in the 8MM will grow by
21.8 over the next decade, from 10,112,797
diagnosed prevalent cases in 2013 to 12,316,458
diagnosed prevalent cases in 2023. Feel free to
enquire about this report _at_ http//www.bigmarketr
esearch.com/report-enquiry/190797
4
Report Description
GlobalDatas epidemiological forecast for the
diagnosed prevalent cases of AF in the 8MM is
supported by epidemiologic data from
country-specific studies that are nationally
representative of the entire population in these
markets. This analysis included the most recently
published nationally-representative studies in
the 8MM, which provided the diagnosed prevalence
of AF using uniform diagnostic criteria based on
EKG tests, which facilitated a meaningful
comparison of the forecast for the diagnosed
prevalent cases of AF in the 8MM. Need
Discount? Request here _at_ http//www.bigmarketrese
arch.com/purchase-enquiry/190797
5
Report Description
Scope The Atrial Fibrillation (AF) EpiCast
Report provides an overview of the risk factors,
comorbidities, and the global and historical
trends for AF in the eight major markets (8MM)
(US, France, Germany, Italy, Spain, UK, Japan,
and Canada). It includes a 10-year
epidemiological forecast for the diagnosed
prevalent cases of AF segmented by sex, age (in
five-year age groups, beginning at 40 years and
ending at 85 years), and clinical subtypes
(paroxysmal, persistent, and permanent AF) in
these markets. The AF epidemiology report is
written and developed by Masters- and PhD-level
epidemiologists. The EpiCast Report is in-depth,
high quality, transparent and market-driven,
providing expert analysis of disease trends in
the 8MM.
6
Table of Contents
1.1 List of Tables 1.2 List of Figures 2
Introduction 2.1 Catalyst 2.2 Related Reports
2.3 Upcoming Related Reports 3
Epidemiology 3.1 Disease Background 3.2 Risk
Factors and Comorbidities 3.3 Global Trends 3.4
Forecast Methodology 3.4.1 Sources Used 3.4.2
Forecast Assumptions and Methods 3.4.3 Sources
Not Used
7
Table of Contents
3.5 Epidemiological Forecast for Atrial
Fibrillation (2013-2023) 3.5.1 Diagnosed
Prevalent Cases of Atrial Fibrillation 3.5.2
Age-Specific Diagnosed Prevalent Cases of Atrial
Fibrillation 3.5.3 Sex-Specific Diagnosed
Prevalent Cases of Atrial Fibrillation 3.5.4
Age-Standardized Diagnosed Prevalence of Atrial
Fibrillation 3.5.5 Diagnosed Prevalent Cases of
Atrial Fibrillation by Clinical Subtypes 3.6
Discussion 3.6.1 Epidemiological Forecast
Insight 3.6.2 Limitations of the Analysis 3.6.3
Strengths of the Analysis 4 Appendix 4.1
Bibliography 4.2 About the Authors 4.2.1
Epidemiologists 4.2.2 Reviewers 4.2.3 Global
Director of Therapy Analysis and Epidemiology
8
Report Description

• Reasons to buy
• Develop business strategies by understanding the
  trends shaping and driving the global AF market.
• Quantify patient populations in the global AF
  market to improve product design, pricing, and
  launch plans.
• Organize sales and marketing efforts by
  identifying the sex and age groups that present
  the best opportunities for AF therapeutics in
  each of the markets covered.

9
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/epicast-report-at
rial-fibrillation-epidemiology-forecast-to-2023-ma
rket
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
help_at_bigmarketresearch.com